inclusion criera : * patient ≥ 18 years old and ≤ 75 years old * laboratory proved infection by covid-19 by rt-pcr on a respiratory biological sample within 2 days * hospitalization is required according to current local recommendations * patient affiliated to a social security regime * patient able to give free, informed and written consent exclusion criteria : * oxygen flow rate \>8l/min at inclusion * current treatment with any inhaled steroid (any other form of steroid administration does not exclude the patient) * intensive care unit is required for the patient (based on investigator judgement) * patient with cognitive impairment which do not guarantee proper use of the treatment by the patient himself * pregnant (positive β-hcg at inclusion) or breastfeeding women * participation in another interventional drug study involving human participants and concerning covid-19 infection or being in the exclusion period of a previous study involving human participants * contraindications to the treatments (history of hypersensitivity) * patient admitted for isolation, for social reason or due to comorbidities without gravity sign * long-term patient treated with digitalis, disopyramide, procainamide or phenothiazine that could lengthen the qt space

inclusion criera : * patient ≥ 18 years old and ≤ 75 years old * laboratory proved infection by covid-19 by rt-pcr on a respiratory biological sample within 2 days * hospitalization is required according to current local recommendations * patient affiliated to a social security regime * patient able to give free, informed and written consent exclusion criteria : * oxygen flow rate \>8l/min at inclusion * current treatment with any inhaled steroid (any other form of steroid administration does not exclude the patient) * intensive care unit is required for the patient (based on investigator judgement) * patient with cognitive impairment which do not guarantee proper use of the treatment by the patient himself * pregnant (positive β-hcg at inclusion) or breastfeeding women * participation in another interventional drug study involving human participants and concerning covid-19 infection or being in the exclusion period of a previous study involving human participants * contraindications to the treatments (history of hypersensitivity) * patient admitted for isolation, for social reason or due to comorbidities without gravity sign * long-term patient treated with digitalis, disopyramide, procainamide or phenothiazine that could lengthen the qt space

inclusion criera : - patient ≥ 18 years old and ≤ 75 years old - laboratory proved infection by covid-19 by rt-pcr on a respiratory biological sample within 2 days - hospitalization is required according to current local recommendations - patient affiliated to a social security regime - patient able to give free, informed and written consent exclusion criteria : - oxygen flow rate >8l/min at inclusion - current treatment with any inhaled steroid (any other form of steroid administration does not exclude the patient) - intensive care unit is required for the patient (based on investigator judgement) - patient with cognitive impairment which do not guarantee proper use of the treatment by the patient himself - pregnant (positive β-hcg at inclusion) or breastfeeding women - participation in another interventional drug study involving human participants and concerning covid-19 infection or being in the exclusion period of a previous study involving human participants - contraindications to the treatments (history of hypersensitivity) - patient admitted for isolation, for social reason or due to comorbidities without gravity sign - long-term patient treated with digitalis, disopyramide, procainamide or phenothiazine that could lengthen the qt space

inclusion criera : - patient ≥ 18 years old and ≤ 75 years old - laboratory proved infection by covid-19 by rt-pcr on a respiratory biological sample within 2 days - hospitalization is required according to current local recommendations - patient affiliated to a social security regime - patient able to give free, informed and written consent exclusion criteria : - oxygen flow rate >8l/min at inclusion - current treatment with any inhaled steroid (any other form of steroid administration does not exclude the patient) - intensive care unit is required for the patient (based on investigator judgement) - patient with cognitive impairment which do not guarantee proper use of the treatment by the patient himself - pregnant (positive β-hcg at inclusion) or breastfeeding women - participation in another interventional drug study involving human participants and concerning covid-19 infection or being in the exclusion period of a previous study involving human participants - contraindications to the treatments (history of hypersensitivity) - patient admitted for isolation, for social reason or due to comorbidities without gravity sign - long-term patient treated with digitalis, disopyramide, procainamide or phenothiazine that could lengthen the qt space